EQA Scheme
Contact

Virus Antigen Detection - Panel for the Detection of Influenza A/B Viruses, RSV and SARS-CoV-2 (Ag) (410)

Samples:
5 samples of 0.5 ml
Sample properties:
Liquid cell culture material (inactivated)
Additional Information:
Note: When performing tests using your own swab, please note that the provided sample volume of 0.5 ml is generally sufficient for performing one SARS-CoV-2 test, one influenza virus test, and one RSV test. However, depending on the absorbency of the swab used, a second tube may be necessary. For POCT systems: Please ensure that the sample matrix used in the EQA scheme is suitable for your test system. In case of uncertainty, we recommend contacting the manufacturer or supplier of your device. Cooperation with: Nationales Konsiliarlabor für Coronaviren, Institut für Virologie, Charité - Universitätsmedizin Berlin;
Requirement for EQAS/PT according to Rili-BÄK
Parameters:

Detection of influenza A/B antigen and RSV antigen

Certificate Validity: 12 months
Not subject to Rili-BÄK
Parameters:

Detection of SARS-CoV-2 antigen

Certificate Validity: 12 months
Shipping Information:
Shipping not cooled
Safety Information:
Process as patient sample material

Dates:

Registration deadline:

Sample shipment:

Closing Date:

Mar. (2) June (4) Sep. (5) Nov. (6)
08.01.2027 09.04.2027 25.06.2027 03.09.2027
09.03.2027 08.06.2027 24.08.2027 02.11.2027
26.03.2027 25.06.2027 10.09.2027 19.11.2027
EQAS/PT Experts:

Dr. med. Martin Obermeier

MVZ medizinisches Infektiologiezentrum Berlin AG

 

Oudenarder Strasse 16

13347 Berlin

 

+49 30-34409104-66

obermeier@mvz-mib.de

Dr. rer. nat. Martin Kammel

Institut für Qualitätssicherung in der Virusdiagnostik - IQVD

 

Potsdamer Chaussee 80

14129 Berlin

 

+49 30 8105 4300

m.kammel@iqvd.de